More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From - Diagnostic Testing & Emerging Technologies More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were… . . . read more
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article